MONCTON, NB, March 7, 2018 /CNW/ - Organigram Holdings Inc.
(TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company" or "Organigram"), a
leading licensed producer of medical marijuana based in
Moncton, New Brunswick, is pleased
to announce the appointment of Guillermo
Delmonte as the President, of its new international
division. Mr. Delmonte will assume his new role effective
March 8, 2017.
A proven leader in the international cannabis and CBD
marketplace, Mr. Delmonte joins the Organigram team following two
and a half years as Chief Executive Officer at ICC Labs Inc., a
leading international hemp and cannabis producer. In this role, he
successfully oversaw the ICC's initial public offering (IPO) as the
first South American cannabis company to go public with a first day
valuation of more than $120 million
CAD.
"Guillermo is a tremendous addition to the Organigram team,"
says Greg Engel, CEO, Organigram.
"His deep understanding of global markets and opportunities, track
record of international leadership, and extensive network around
the world are key to our international plans as we target
Europe, Australia and other regions worldwide in the
burgeoning cannabis and hemp marketplace."
As President of this new venture, Mr. Delmonte will lead the
planning and execution of the Company's international expansion
strategy and work out of multiple locations on behalf of the
Company.
Larry Rogers, Vice President of
International Business Development, Organigram, will work closely
with Mr. Delmonte. "Our plans for international expansion are
robust and ambitious," says Engel. "With the full force of
Guillermo's and Larry's expertise and vision behind these efforts,
we continue to build one of the strongest executive teams in the
global cannabis marketplace."
Mr. Delmonte has also held financial and business development
leadership roles at companies including BBVA Bank, Technit Group,
Credit Agricole Bank, United Nations Uruguay and Bank ITAU.
Mr. Delmonte is a graduate of ORT, University Montevideo
(Uruguay), Institut d'Estudis
Financiers Barcelona (Spain), and
IEEM Montevideo University (Uruguay).
For more information, visit www.Organigram.ca
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of medical marijuana in Canada. Organigram is focused on producing the
highest quality, condition specific medical marijuana for patients
in Canada. Organigram's facility
is located in Moncton, New
Brunswick and the Company is regulated by the Access to
Cannabis for Medical Purposes Regulations ("ACMPR").
Organigram has been ranked in the top ten Clean Technology
& Life Sciences Sector on the TSX Venture Exchange 50.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors - including the availability of
funds, consummation of definitive documentation, the results of
financing efforts, crop yields - that could cause actual results to
differ materially from the Company's expectations are disclosed in
the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the
date of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
SOURCE OrganiGram